academic article

• Placebo-controlled, double-blind trial of intravenous ribavirin for the treatment of hantavirus cardiopulmonary syndrome in North America..  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.  39:1307-1313. 2004